Dr Scott T. Aaronson (USA)
Director of Clinical Research Programs, Sheppard Pratt Health System and Adjunct Professor in the Department of Psychiatry, University of Maryland
Dr Scott Aaronson, MD, is director of clinical research programs at Sheppard Pratt Health System in Baltimore, Maryland. He is an Adjunct Professor in the Department of Psychiatry at the University of Maryland School of Medicine. Dr Aaronson specializes in treatment-resistant affective disorders. His work focuses on the development of various novel paradigms including psychedelic-assisted psychotherapy to treat severe mood disorders. He is a member of the Board of Directors of the Clinical TMS Society and the American Society for Clinical Psychopharmacology. Dr Aaronson earned his MD with honors from Harvard Medical School and completed a residency in psychiatry at McLean Hospital. He is a Distinguished Life Fellow of the American Psychiatric Association and a Fellow of the American College of Psychiatrists.
Dr Gabby Agin-Liebes (USA)
Research Fellow, Substance Use Disorders Treatment & Services Department of Psychiatry & Behavioral Sciences | Weill Institute for Neurosciences Zuckerberg San Francisco General/UCSF School of Medicine
Gabby Agin-Liebes, PhD is a clinical psychologist with 10 years of experience working as a therapist and investigator on academic trials with psilocybin-assisted therapy at New York University, Yale and UC San Francisco (UCSF). Her research has applied quantitative and qualitative methodologies within psilocybin-assisted and mindful self-compassion-based interventions to treat substance use and trauma-based disorders. She is currently a National Institutes of Health-funded research fellow at UCSF studying novel interventions for treating opioid addiction and chronic pain that target dysregulated emotion regulation and attentional bias processes. She is the lead author on a paper published earlier this year, and featured in several news outlets, which found that psilocybin-therapy led to sustained clinical remission from depression and anxiety in individuals with cancer up to 4.5 years later.
Dr Tanveer Ahmed
FRANZCP , MBBS
Psychiatrist and Author
Dr Tanveer Ahmed is a psychiatrist, author and columnist. He works in the public, private and forensic sectors. He is an Adjunct lecturer at UNSW. He writes a regular column for the Australian Financial Review. His last book Fragile Nation examines the rise of mental health disorders through patient stories. He has served on local government, the government advisory body called the Australian Multicultural Council, the Advertising Standards Board and as a Governor of the Smith Family. He was previously chosen by a PMs committee as one of a hundred future leaders of Australia.
Dr Mahsheed Ansari
BA, LLB, MA, PHD
Centre for Islamic Studies and Civilisation (CISAC) Charles Sturt University
Dr Mahsheed Ansari is lecturer in Islamic Studies and the Higher Degrees Research Coordinator at the Centre for Islamic Studies & Civilisation, Charles Sturt University. Her research interests include the history of Islamic thought, spirituality and culture. She is also a historian interested in the formation and development of minority communities in Australia. She is currently working on the Muslim heritage research project at the Public and Contextual Theology Research Centre at Charles Sturt University. Mahsheed has been a reader in Islamic thought for over 18 years. She is also community activist working in the areas of interfaith dialogue, social harmony and leadership-mentoring programs with Muslim youth and Muslim women for over a decade.
Barrister, Author & Company Director
Greg Barns is a barrister, author and company director. Greg worked as a senior adviser to a number of federal and state ministers and leaders and ran the 1999 Republic Referendum campaign with Malcolm Turnbull. He is former National President of the Australian Lawyers Alliance and is a regular commentator on human rights issues. Greg has been a leading advocate of drug law reform in Australia and has written extensively on the subject. He has also written and spoken publicly about his own experience living with depression and anxiety. Greg is the author of four books on Australian politics. He practices from Hobart and Melbourne and has acted in a number of medical cannabis cases.
Prof James Bennett-Levy
BA(HONS), MPHIL (CLIN PSYCH), PH.D
Professor of Mental Health and Psychological Wellbeing, University of Sydney
James Bennett-Levy is a clinical psychologist and Professor in Mental Health and Psychological Wellbeing at the University of Sydney. He is internationally known as a trainer of psychotherapists having taught in 25 countries. He is also as one of the world’s leading researchers on therapist training. In particular, his models of therapist skill development and his pioneering self-experiential approach to therapist training, known as self-practice/self-reflection (SP/SR), have been widely adopted. He is Series Editor for Guilford Press’ Self-practice/Self-reflection Guides for Therapists and has co-written two books in the series. Previously, he has co-authored 3 Oxford University Press books for therapists.
Prof Michael Berk
PH.D., MBBCH, MMED, FF(PSYCH)SA, FRANCZP
NHMRC Senior Principal Research Fellow
Michael Berk is an NHMRC Senior Principal Research Fellow at Deakin University, where he heads the IMPACT institute. He is listed by Thompson Reuters as amongst the world’s most influential scientific minds (2015-2019) and was awarded the Brain & Behaviour (NARSAD) Colvin Award for Mood Disorders in 2015 and the Victoria Prize for life sciences in 2019. He is past president of the International Society for Bipolar Disorders and the Australasian Society for Bipolar and Depressive Disorders. His major interests are in the discovery and implementation of novel therapies.
Prof Ashley Bush
MB BS, DPM, FRANZCP, PHD, FTSE, FAHMS, FAPA
NHMRC Senior Principal Research Fellow, Director of the Melbourne Dementia Research Centre
Ashley Bush (MB BS, DPM, FRANZCP, PhD, FTSE, FAHMS, FAPA), NHMRC SPRF is Director of the Melbourne Dementia Research Centre and Oxidation Biology Unit at The Florey Institute of Neuroscience & Mental Health, University of Melbourne. His outstanding contributions to the neuroscience field include his discovery of the importance of metals and oxidative stress in neurological disease, providing insights into the pathogenesis of Alzheimer’s disease, ALS, Parkinson’s and Huntington’s diseases. He is Co-Director of Biomarker Development for the AIBL Study of Ageing. He is Professor of Neuroscience, and Honorary Professorial Fellow of Psychiatry and Clinical Pathology at the University of Melbourne, with courtesy staff appointments in Psychiatry and Radiology at Massachusetts General Hospital, USA. He is Founding Scientist for Prana Biotechnology, Cogstate and Collaborative Medicinal Development P/L, and Deputy Chair at the Melbourne Academic Centre for Health. Bush has 464 publications (45,000+ citations) and 28 patents, is ad hoc reviewer of 48 journals, and has presented 330+ lectures (212+ international, 26 Plenary). He is one of the most highly-cited neuroscientists in Australia, is rated in the top 1% of neuroscience researchers worldwide for high impact citations (2014-2016, 2018-2019), and one of the World’s Most Influential Scientific Minds (Thomson Reuters/Clarivate Analytics).
Dr David Caldicott
B.Sc. (Hons), MBBS, FRCEM, DipMedTox
Emergency Medicine Consultant
David Caldicott is an Irish Emergency Consultant, living and working in Canberra – he holds conjoint academic positions with the University of Canberra, and the Australian National University.
David is the co-recipient of an NH&MRC Partnership grant as part of the ‘Driving Change project’. He is currently the Clinical Lead at the Australian Drug Observatory of The ANU.
David has always been ‘disruptive’. He wrote and delivered Australia’s first medicinal cannabis course, conceived to teach clinicians the science behind the headlines. He also designed & negotiated Australia’s first sanctioned ‘pill testing’ trial in the ACT in 2018. David has an Irishman’s interest in influencing politics to effect evidence based policy, and is an expert on illicit drugs for the Australian Science Media Centre.
Dr Robin Carhart-Harris (UK)
Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. At Imperial, he has run and overseen brain imaging studies involving LSD, psilocybin, MDMA and DMT, plus a clinical trial of psilocybin for treatment-resistant depression, and a current study comparing psilocybin with escitalopram for major depressive disorder. In 2019, he set-up the Centre for Psychedelic Research at Imperial and he also an honorary position with the University of Oxford. Two of his most influential works include the ‘Entropic Brain Hypothesis’ and ‘REBUS and the anarchic brain’.
Dr Ted Cassidy
Psychiatrist and Co-Founder of TMS Australia
Dr Ted Cassidy is a Founder of TMS Australia – Australia’s largest provider of outpatient Depression & PTSD treatment using innovative Transcranial Magnetic Stimulation (TMS) technology. He is Chief Medical Officer and a Director of TMS Australia. He is responsible for the clinical operations and patient care in TMS Australia’s outpatient treatment centres.
Dr Cassidy previously founded The Hills Clinic group. The Hills Clinic Hospital was the first purpose built private mental health hospital in Australia when it opened in 2011. Dr Cassidy is a Psychiatrist, Fellow of the Royal Australian and New Zealand College of Psychiatrists and medical graduate of the University of Sydney.
Dr Lynette Chazan
MBBS, FRANZCP, MPM
Psychiatrist, Psychoanalytic Psychotherapist & Teacher
Dr Lynette Chazan has thirty years experience in practising, supervising and teaching psychoanalytic psychotherapy and facilitating Balint Groups. She currently works in private practice and is Co-ordinator of Psychotherapy Training for Psychiatrists at Monash Health.
Dr Mark Cross
MBChB, MRCPsych(UK), FRANZCP
Psychiatrist and SANE Board Director
Doctor Mark Cross is a psychiatrist with clinical experience over 3 decades. He graduated as a doctor in Cape Town, specialised in the UK, and has worked as a specialist in Sydney since 2005. He holds senior conjoint lecturer positions at the Universities of NSW and Western Sydney. Mark has special interests in sexuality issues, Mental Health in the workplace and improving the care and quality of life of people with lived experience, and carers. In 2015, he received the Royal Australian and New Zealand College of Psychiatrists NSW Branch Meritorious Award for his “significant contribution” to psychiatry. Mark is the author of ‘Anxiety’ and co-author of ‘Changing Minds,’ both published by ABC Books/Harper Collins, and was the Lead Psychiatrist in the ABC TV series ‘Changing Minds.’ He is a well-respected speaker on Mental Health issues, a SANE Australia board member, and a passionate advocate on the importance of preventative mental health.
Dr Wade Davis CM (Canada)
Wade Davis is a writer and photographer whose work has taken him from the Amazon to Tibet, Africa to Australia, Polynesia to the Arctic. Explorer-in-Residence at the National Geographic Society from 2000 to 2013, he is currently Professor of Anthropology and the BC Leadership Chair in Cultures and Ecosystems at Risk at the University of British Columbia.
Wade has authored 22 books, including One River, The Wayfinders and Into the Silence, he holds degrees in anthropology and biology and received his Ph.D. in ethnobotany, all from Harvard University. In 2016, he was made a Member of the Order of Canada. In 2018 he became an Honorary Citizen of Colombia.
Dr James Fadiman (USA)
Psychologist and Author
James Fadiman B.A. (Harvard) M.A., Ph.D. (Stanford) began his personal psychedelic research a few weeks before starting his graduate work at Stanford where he did his dissertation on the effectiveness of LSD-assisted therapy. During the research lull of 40 years, he has held a variety of teaching (San Francisco State, Brandeis, and Stanford) consulting, training, counseling and editorial positions. He has taught in psychology departments, design engineering, and for three decades, at the Institute of Transpersonal Psychology (now Sofia University) that he co-founded.
He has published textbooks, professional books, a self-help book, a novel, and a series of videos, Drugs: the children are choosing for National Public Television. His books have been published in 8 languages. He has been the subject of a one-hour documentary released by Page3 Films, featured in a National Geographic documentary and had three solo shows of his nature photography.
He had his own consulting firm and sat on two non-profit boards as well as having been the president of several small natural resource companies. He has been involved in researching psychedelic for spiritual, therapeutic and creative uses and is known for his pioneering work on microdosing . He has published The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys, and most recently, Your Symphony of Selves: Discover and Understand More of Who You Are
Amanda Feilding (UK)
Founder and Executive Director of the Beckley Foundation
Amanda Feilding is the Founder and Executive Director of the Beckley Foundation, and is widely recognised as one of the driving forces behind the current psychedelic research renaissance. By establishing key research collaborations with some of the world’s most prestigious universities, she has propelled the field forward over the last 20 years, conducting several landmark studies, such as the world’s first LSD brain imaging study.
Since its inception, the Beckley Foundation has been at the forefront of the development of evidence-based drug policy. Through a series of pivotal international seminars at the House of Lords, over 50 much-cited reports and numerous meetings with thought-leaders, academics, policy-makers and the public, Amanda has ensured that the Beckley Foundation is a leader in the movement for drug policy reform. Through her work with the Beckley Foundation, Amanda is bridging the gap between science and policy, allowing them to complement and inform one another, ultimately harnessing our knowledge of the benefits of many prohibited substances to maximise human wellbeing.
Prof Paul Fitzgerald
MBBS, MPM, Ph.D, FRANZCP
Professor of Psychiatry at Monash University and Director of the Epworth Centre for Innovation in Mental Health
Paul Fitzgerald is Professor of Psychiatry at Monash University and Director of the Epworth Centre for Innovation in Mental Health based at Epworth Camberwell. He is a qualified psychiatrist, has a Masters of Psychological Medicine and research PhD. His main clinical and academic interest is in the development, evaluation and clinical translation of new therapies for mental health conditions. His research program has been mainly focussed on various forms of brain stimulation including transcranial magnetic stimulation (TMS), transcranial alternating current stimulation, magnetic seizure therapy and deep brain stimulation.
He has conducted over twenty clinical trials in depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer’s disease along with numerous experimental studies. He has established multiple clinical TMS services, is a founder and board member of TMS Clinics Australia, and established Australia’s first TMS clinical training program. He has had continual NHMRC grant support for almost 20 years.
Prof David Forbes
BA(Hons), MA (Clin Psych), Ph.D
David Forbes is the Director of Phoenix Australia – Centre for Posttraumatic Mental Health and Professor in the Department of Psychiatry, University of Melbourne. He has over twenty five years’ experience in the assessment and treatment of mental health problems in trauma survivors, with a speciality in military, veteran and emergency services mental health. He led the development of the Australian Guidelines for the Treatment of Posttraumatic Stress Disorder (PTSD) approved by the National Health and Medical Research Council and is Vice Chair of the International (ISTSS) PTSD Guidelines. He has published over 160 scientific papers in the international literature and sits on many Commonwealth government policy and scientific advisory panels and academic journal editorial boards.
Prof Paul Frijters (UK)
PhD, MS, BS
Research Fellow London School of Economics
Paul Frijters is a Professor of Wellbeing Economics at the London School of Economics: from 2016-nov 2019 at the Center for Economic Performance, thereafter at the Department of Social Policy.
He completed his Masters in Econometrics at the University of Groningen, including a seven-month stay in Durban, South Africa before completing a PhD through the University of Amsterdam. He has also engaged in teaching and research at the University of Melbourne, the Australian National University, QUT, UQ, and now the LSE.
Professor Fritjers specializes in applied micro-econometrics, including labor, happiness, and health economics, though he has also worked on pure theoretical topics in macro and micro fields. His main area of interest is in analyzing how socio-economic variables affect the human life experience and the “unanswerable” economic mysteries in life.
Professor Frijters is a prominent research economist and has published over 150 papers in fields including unemployment policy, discrimination and economic development.
He was the Research Director of the Rumici Project, a project sponsored by the Australian Ministry of Foreign Aid (AusAid), and is also a co-editor of the journal, Economic Record. In 2009 he was voted Australia’s best young economist under 40 by the Australian Economic Society. He joined IZA as a Research Fellow in April 2010.
Dr Albert Garcia-Romeu (USA)
B.A., PH.D., M.A
A/Professor Johns Hopkins University School of Medicine
Albert Garcia-Romeu, Ph.D. is a member of the Psychiatry and Behavioral Sciences faculty at the Johns Hopkins University School of Medicine and a Guest Researcher at the National Institute on Drug Abuse Intramural Research Program. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. He received his doctorate in Psychology in 2012 from the Institute of Transpersonal Psychology in Palo Alto, CA, where he studied self-transcendence and meditation, and their relationship to mental health. His current research interests include clinical applications of psychedelics, mindfulness, and altered states of consciousness and their underlying psychological mechanisms. He additionally studies real-world drug use patterns and impacts on public health, and the role of spirituality in mental health and addiction. He is a founding member of the Johns Hopkins Center for Psychedelic and Consciousness Research and the International Society for Research on Psychedelics.
Dr Ingmar Gorman (USA)
Psychologist and Co-Founder of Fluence
Dr Ingmar Gorman is the co-founder of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. He is a psychologist specializing in helping people who use psychedelics and other psychoactive compounds. He received his clinical training at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University in 2017. Dr Gorman was formerly the Director of the Psychedelic Education and Continuing Care Program, formerly site co-principal investigator and current active therapist on a Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder and active therapist on a Phase 2 clinical trial of Psilocybin-assisted Psychotherapy for Treatment Resistant Depression.
Dr George Halasz
Consultant Child and Adolescent Psychiatrist and Adjunct Senior Lecturer, Monash University
George Halasz is a consultant child and adolescent psychiatrist and Adjunct Senior Lecturer at School of Psychology and Psychiatry, Faculty of Medicine, Nursing and Health Sciences, Monash University, as well as in private psychiatry practice.
From 1992–2005 he was a member of the Editorial Board of the Australian and New Zealand Journal of Psychiatry, and the Editorial Committee of Australasian Psychiatry (2005–current). He was consultant to chapters in Psychodynamic Diagnostic Manual (PDM)–2 (edited by V. Lingiardi & N. McWilliams, Guilford Press, 2017).
His special areas of interests and publications in books and peer-reviewed journals include ADHD, Holocaust trauma and inter-generational trauma transmission, trauma informed care, child/adolescent psychotherapy and ethics, children of parents with mental illness (COPMI), and the interface between psychiatry and religion.
Over the last twenty years he has lectured on trauma related themes in the UK, Israel, Poland, Hong Kong, US, NZ, and Australia. He was a regular panelist on Melbourne Radio Station RRR’s “Radiotherapy” for close to twenty-five years.
Dr Mark Hardy
B.Sc (Med)., M.B.,B.S., FRACGP, FAChAM (RACP)
Medical Director, CA Clinics and Visiting Medical Officer, Addiction Medicine, Northern Beaches Hospital, The Sydney Clinic
Dr Mark Hardy was born and raised in the northern beaches of Sydney. After attending local schools, he attended the University of Sydney. There, he concurrently completed his medical degree, along with a Bachelor of Science (Medical) majoring in Toxicology. After working in women’s health and general practice, Mark pursued training in Addiction Medicine at The Langton Centre, Surry Hills and Royal North Shore Hospital. Upon completion, he worked as a Staff Specialist at Northern Sydney Local Health District from 2011 to 2018, working mainly in the Northern Beaches. He held the position of Acting Clinical Director of the Drug and Alcohol Service from 2014-16 and from 2017-18. In 2018, he transitioned to private practice, in the lead-up to the opening of the new Northern Beaches Hospital. He has additionally consulted to other private hospitals, including The Sydney Clinic, The Hills Private Hospital and Mosman Private Hospital.
His professional interests are in the addiction field are in alcohol and other drugs detoxification, opioid treatment and risk management, prescription drug misuse and medicinal cannabis. He is a current member of the Opioid Pharmacotherapy Subcommittee for NSW Health. He has been seconded to the World Health Organisation to assist in preparation and delivery of training for trainers for both pharmacological and psychosocial treatments for opioid and other substance dependence. He has provided education internationally to GPs and specialists in the Middle East, Asia, Africa and Oceania and has presented education and research at international conferences, both in Australia and abroad.
His work in cannabis detoxification, allied with his general medical experience, has led him to a new field of endeavour, that of medicinal cannabis prescribing for specific conditions. Dr Hardy is the Medical Director of CA Clinics, which operates as an access clinic for patients with Chronic Pain, Anxiety Disorders (including PTSD), Movement Disorders, Sleep Dysfunction, Chemotherapy-Induced Nausea and Vomiting, Palliative Care and Epilepsy. The application of these treatments requires special access through the Therapeutic Goods Administration in Australia, which can be facilitated if treatment is indicated.
Barrister and Solicitor of the High Court of Australia and Author
David Heilpern was appointed as a Magistrate in 1998, and was at the time the youngest magistrate in Australia. He ‘retired’ in May 2020. He sat in the criminal, mining, family, industrial, coronial and children’s jurisdictions of the Local Court, and was the Senior Civil Magistrate for five years. During his time on the bench, David was the principal educator for new magistrates throughout Australia and the Pacific and made several important reported decisions on criminal, environmental and evidence law.
Prior to his appointment, David was a litigation lawyer on the North Coast where he co-founded the law school at Southern Cross University, rising to becoming the Acting Dean in 1996. He maintained a litigation practice throughout this time, representing a wide range of defendants including high profile clients North East Forrest Alliance and Nimbin Hemp. During this time David graduated with a Masters in Law and was pronounced the Alumni of the Decade for the University in 2005.
David has written four published books, three of which have now had multiple editions, dozens of refereed journal articles, and is a prize-winning short story writer and poet.
David has recently been appointed as a Professional Practice Professor and Adjunct Professor at the School of Law and Justice at Southern Cross University. He has returned to the practice of law and his writing is now focussed on drug law reform, aboriginal overrepresentation in the criminal justice system and environmental activism.
Prof Gregg Henriques (USA)
PhD, MS, BS
Dr. Gregg Henriques is Professor of Graduate Psychology at James Madison University in the Combined-Integrated Doctoral Program in Clinical and School Psychology. Dr. Henriques received his Ph.D. in Clinical Psychology from the University of Vermont and did his post-doctoral training at the University of Pennsylvania. Dr. Henriques’ primary area of scholarly interest is in developing a “unified framework” for both the science and practice of psychology. He has authored the book, A New Unified Theory of Psychology and developed a popular blog on Psychology Today, Theory of Knowledge, where he has authored over 350 essays on psychology, philosophy, politics, and mental health. He is a Fellow of the American Psychological Association, has won numerous awards for teaching, scholarship, and service, and launched and leads the Theory of Knowledge academic society. He has expertise in theoretical psychology, unified approaches to psychotherapy, psychological well-being, personality functioning, depression, and suicidal behavior.
Dr Karen Hitchcock
B.A.(Hons), B.Med, FRACP, PhD
General Physician and Author
Dr Hitchcock is a specialist physician (acute and general medicine) and author. Outside of the acute hospital wards her clinical work has focused on pain, fatigue, medically unexplained and functional symptoms, anxiety and obesity. She was one of the first authorised prescribers of medicinal cannabis in Australia and currently runs a cannabis clinic in South Yarra. She holds a PhD in English and writes for the Monthly magazine. Her Quarterly Essay Dear Life: On caring for the elderly was published in 2015 and republished as an expanded edition book in 2016. Her collection of short fiction Little White Slips won the 2010 Queensland Premier’s Steele Rudd award. Her new book The Medicine: A Doctor’s Notes was published in February 2020.
Prof Malcolm Hopwood
MBBS, MPM, MD, FRANZCP
Ramsay Health Care Professor of Psychiatry, University of Melbourne
Professor Malcolm Hopwood is the Ramsay Health Care Professor of Psychiatry, University of Melbourne; based at the Albert Road Clinic in Melbourne Australia. His specialises in clinical aspects of mood and anxiety disorders, psychopharmacology and psychiatric aspects of acquired brain injury and epilepsy. He leads a research team within the professorial Psychiatry Unit at the Albert Road Clinic examining g the application of novel treatments in mood disorders. In the past, he led the Psychological Trauma Recovery Service, incorporating the Veterans Psychiatry Unit and the Victorian Brain Disorders Program, Austin Health. He has held senior positions within the Royal Australian and New Zealand College of Psychiatrists including past Chairmanships of the Victorian Branch and the Board of Research, and was President of the College from 2015-2017. In 2017 Professor Hopwood was installed as President-Elect of the Asian Federation of Psychiatric Associations (AFPA).
B. Ec (Monash)
Founder and CEO of Cannatrek Limited
Tommy Huppert, Founder and CEO of Cannatrek Limited, is a start-up entrepreneur and medicinal cannabis health economist. Cannatrek is one of the first enterprises in Australia to secure all federal and state government licenses to import cannabis seeds, research, grow, process, manufacture, and distribute medicinal cannabis products. His mission is to not only place the cannabis plant front and centre in production excellence but to funnel resources for patient care solutions and deliver affordable medicine to those in need.
He has established the “Seed to Patient” business model combining cutting edge cultivation expertise and world-class manufacturing practices to deliver high quality products, with a clinical research focus on mental health. This strategy has been instrumental in Cannatrek’s Major Project Status, a Commonwealth Government’s recognition of the strategic significance of a project to Australia. He is a frequent speaker in various medicinal cannabis conferences in and outside Australia.
Prof Matthew W. Johnson (USA)
Associate Director at the Johns Hopkins Center for Psychedelic & Consciousness Research
Matthew W. Johnson, Ph.D., Professor at Johns Hopkins, is an expert on psychedelics, other drugs, and addiction. Working with psychedelics for more than 15 years, he has published more than100 papers with 43 on psychedelics. Matt published psychedelic safety guidelines in 2008, helping to resurrect psychedelic research. He published the first research on psychedelic treatment of tobacco addiction in 2014, and the largest study of psilocybin in treating cancer distress in 2016. His recent psilocybin review recommended placement in Schedule-IV upon medical approval. He has personally guided more than 100 psychedelic sessions. Matt also conducts behavioral economic research on both addiction and sexual risk. He has published studies on nearly all psychoactive drugs classes, and is President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association. Matt has been interviewed by the New York Times, Washington Post, Wall Street Journal, BBC, CNN, Fox Business News, NPR, CBS News, and NBC News.
MBA, member of the Institute of Chartered Accountants
Business Strategist and Finance Executive
Mark Joiner, now retired and living in the Byron Bay region of Australia, is a former business strategist and finance executive. He was for many years the global head of corporate strategy at the Boston Consulting Group, ultimately based in New York, before entering banking as a Chief Financial Officer, first with Citigroup and then with National Australia Bank, where he was Executive Director Finance.
Today, he holds directorships with a small number of financial institutions, while devoting his capacity to the sustainability challenges we face through a wide range of initiatives including education, impact investing and programs supporting community resilience.
Dr Linda Kader
MBBS, MD, FRANZCP, Cert Psychodyn Psychotherapy, Cert Glob Mntl Hlth (Harvard)
Psychiatrist and Senior Lecturer at the Department of Psychiatry, University of Melbourne
Linda Kader is a psychiatrist & psychotherapist based in Melbourne, Australia. She currently works at The Royal Melbourne and The Royal Children’s Hospitals. Her areas of expertise include Early Intervention in Youth and Adult Psychiatry. Linda is committed to bring psychotherapeutic theories to understand the struggles of human minds in a deeper humanistic manner alongside evidence-based biological models of illnesses. Linda is trained both in Psychodynamic and Contemplative (Buddhism-based) Psychotherapy to assist her patients, when appropriate, with their difficulties. She worked at Orygen Youth Health for over a decade and conducted clinical research in psychosis and remains passionate about research & innovation in Psychiatry.
Linda is a Senior Lecturer at the Department of Psychiatry, University of Melbourne and has maintained long-standing interest in teaching. She served as the Deputy Dean at Northern Clinical School in the Faculty of Medicine Dentistry & Health Sciences, University of Melbourne. Linda has an interest & intellectual curiosity to understand the mechanisms, & usefulness of psychedelics in Psychiatry.
Rabbi Zac Kamenetz
Educator, Rabbi and aspiring Healer
Rabbi Zac Kamenetz is the founder and CEO of Shefa, an education and advocacy organization dedicated to supporting individual and collective healing, self-discovery, and transformation by unlocking the practical wisdom of Jewish mystical traditions, sharing them as a guiding force. Shefa provides seekers with a Jewish framework for direct spiritual experience, prepares communities for the integration of psychedelics into mainstream therapeutic and religious culture, and empowers them to bring the wisdom, wellbeing, and joy that arise from direct perception of the divine into their daily lives. Zac received rabbinic ordination in 2012 an MA from the Graduate Theological Union/UC Berkeley. A sought-after speaker and educator, Zac lives in Berkeley, CA with his wife and their daughter.
Pharmaceutical and Clinical Trial Research Specialist
Michael Kornhauser’s research has focussed on psychiatric and neurodenegerative diseases for close to a decade. His aim is to help develop and make available new therapies for people suffering from conditions which are currently poorly managed. As the National Head of Clinical Trial Research at HammondCare, Michael has been at the forefront of ground-breaking Alzheimer’s Disease research and has had the opportunity to be part of unique pre-clinical and clinical trial projects.
His prior role as the Director of Clinical Trial Research at Monash Alfred Psychiatry Research Centre saw him negotiate every aspect of the clinical development process and facilitated collaboration with both big pharma and small biotech in order to bring game changing new therapies to the public. His research knowledge and experience has seen him repeatedly invited to present guest lectures at universities, the most recent being Monash University and Australian Christian University.
Dr Adele Lafrance (Canada/USA)
Clinical Psychologist, Research Scientist and Author
Adele Lafrance is a clinical psychologist, research scientist, and best-selling author. A frequent speaker at professional conferences worldwide, Dr. Lafrance has published extensively in the field of emotion and health, including a clinical manual to support intergenerational family healing published by the American Psychological Association. Dr. Lafrance is a leader in the research and practice of psychedelic medicine, with a focus on ayahuasca, psilocybin and MDMA. She studies mechanisms of change, including spirituality and emotion processing, as well as psychedelic-assisted psychotherapy to support the treatment of eating disorders. Dr. Lafrance also has a keen interest in the application of psychedelic medicine in the context of family therapy.
Prof Andrew Lawrence
NHMRC Principal Research Fellow & Division Head at the Florey Institute of Neuroscience & Mental Health
Professor Andrew J Lawrence is an NHMRC Principal Research Fellow at the Florey Institute of Neuroscience & Mental Health where he is a Division Head, leader of the Mental Health Research Theme and runs the Addiction Neuroscience laboratory. Andrew has published over 250 original articles & reviews, and been cited >10,000 times. Andrew was Treasurer of the Australasian Neuroscience Society (2002-2008) and is a Fellow of the British Pharmacological Society.
He was Senior Editor of The British Journal of Pharmacology (2007-2014), is currently Editor in Chief of Pharmacology Research & Perspectives and sits on numerous other editorial boards, including Addiction Biology. Andrew was recently President of the Asian-Pacific Society for Neurochemistry (2014-16) & is currently a member of the Board of Directors of the International Society for Biomedical Research on Alcoholism. In 2017 Andrew delivered the Lawrie Austin Plenary lecture at the Australasian Neuroscience Society.
Human Rights Lawyer
Scott A. Leckie is an international Human Rights lawyer, Law Professor and Director and Founder of Displacement Solutions, an NGO dedicated to resolving cases of forced displacement throughout the world, in particular displacement caused by climate change. He also founded and directs Oneness World Foundation (www.onenessworld.org), a think tank exploring questions of world-centric political evolution and new forms of global governance.
He hosts Jointly Venturing, a podcast dedicated to the question of world citizenship, and manages the One House, One Family initiative, an ongoing project in Bangladesh building homes for climate displaced families. He regularly advises a number of United Nations agencies and conceived of and was the driving force behind more than 100 international human rights legal and other normative standards, including UN resolutions – most recently the Peninsula Principles on Climate Displacement Within States. He has written 22 books and over 250 major articles and reports.
Pastor Graham Long AM
The Wayside Chapel
At the time that Wayside called him into Ministry, Graham was a postie. He’d almost perfected riding a little motor bike when Wayside called him to be their next Minister. In his first life, Graham was a social worker in South Australia, specialising in the field of child protection. Graham trained for ministry from 1979 to 1982. After a few years in church ministry, Graham became a chaplain to Parramatta Prison and he ran a church welfare agency. Academically, after ordination, Graham pursued studies in philosophy achieving degrees from Catholic Theological Union and from the Catholic Institute of Sydney. A Masters honours in philosophy was halted when a near fatal motorcycle accident changed all of life’s priorities in 2001. Graham has been married to Robyn for 49 years and together they have two children and five grandchildren. Graham is the author of three books. Graham was named NSW Local Hero in the Australia Day awards of 2014 made a Member of the Order of Australia on the Queen’s Birthday 2015.
Dr Paul MacLeman
MBA, BVSC, GRAD DIP ENG (TECH MGT), GRAD CERT ENG (PROCESS DESIGN), GAIDC
Paul has over 25 years’ experience across all phases of the life sciences sector. With a career-spanning veterinary practice, pharmaceutical development and manufacturing, biotechnology, diagnostics and finance, Paul has expertise in capital raising, business development, technology commercialisation, and sales and marketing globally.
He has founded life sciences start-ups in the biologics area and worked in investment banking focusing on the analysis and financing of technology companies. Paul has previously served as Chairman and/or CEO of several VC funded, ASX, NASDAQ, CSE and TSX listed companies. Paul is also current Executive Chairman of Isla Pharmaceuticals Inc. and is a Chairman of AdAlta Limited and Non-Executive Director of Sypharma Pty Limited. Paul serves on a number of NFP and government advisory roles.
Dr Gabor Maté CM (Canada)
BA, MD, Doctor of Laws (honoris causa)
Physician and Author
Gabor Maté (pronunciation: GAH-bor MAH-tay) is a retired physician who, after 20 years of family practice and palliative care experience, worked for over a decade in Vancouver’s Downtown East Side with patients challenged by drug addiction and mental illness. The bestselling author of four books published in twenty-five languages, Gabor is an internationally renowned speaker highly sought after for his expertise on addiction, trauma, childhood development, and the relationship of stress and illness.
His book on addiction received the Hubert Evans Prize for literary non-fiction. For his groundbreaking medical work and writing he has been awarded the Order of Canada, his country’s highest civilian distinction, and the Civic Merit Award from his hometown, Vancouver. His books include In the Realm of Hungry Ghosts: Close Encounters With Addiction; When the Body Says No; The Cost of Hidden Stress; Scattered Minds: The Origins and Healing of Attention Deficit Disorder; and (with Gordon Neufeld) Hold on to Your Kids: Why Parents Need to Matter More Than Peers. To learn more, join his enews list at www.drgabormate.com.
Dennis McKenna (USA)
Ethnopharmacologist, Author, Founding Board Member at the Heffter Research Institute
His doctoral research (University of British Columbia,1984) focused on the ethnopharmacology of ayahuasca and oo-koo-he, two tryptamine-based hallucinogens used by indigenous peoples in the Northwest Amazon. He is a founding board member of the Heffter Research Institute, and was a key organizer and participant in the Hoasca Project, the first biomedical investigation of ayahuasca. He is the younger brother of Terence McKenna.
From 2000 to 2017, he taught courses on Ethnopharmacology and Plants in Human affairs in the Center for Spirituality and Healing at the University of Minnesota. In 2019, in collaboration with colleagues, he incorporated a new non-profit, the McKenna Academy of Natural Philosophy. He emigrated to Canada in the spring of 2019 together with his wife Sheila, and now resides in Abbotsford, B.C.
Prof Rob Moodie AM
Professor of Public Health, University of Melbourne and Adviser to WHO
Rob Moodie is Professor of Public Health at the University of Melbourne and at the University of Malawi. He worked in refugee health care in the Sudan for Save the Children and MSF and for the Aboriginal health service in Alice Springs. He worked for many years on HIV prevention for the Burnet Institute, WHO and UNAIDS. He was CEO of VicHealth from 1998-2007 and from 2008-2011 he chaired the National Preventative Health Taskforce, which recommended the introduction of plain packaging.
He was Victorian Father of the Year in 2005, was unceremoniously dumped as Chair of the Melbourne Storm in 2010 and received an AM in 2014. He has been teaching leadership skills for the last twelve years and is now establishing a program in health leadership in Malawi. Until very recently he chaired the Global Vaccine Alliance’s Evaluation Committee and now advises WHO on health promotion and non-communicable diseases.
Dr David E. Nichols (USA)
David E. Nichols, PhD is an Adjunct Professor of Chemical Biology and Medicinal Chemistry at the University of North Carolina, Chapel Hill. Previously he held the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology and was a Distinguished Professor of Medicinal Chemistry and Molecular Pharmacology at the Purdue University College of Pharmacy. He received his B.S. degree in chemistry from the University of Cincinnati in 1969, and the PhD in Medicinal Chemistry from the University of Iowa in 1973, following which he did postdoctoral work in pharmacology at the University of Iowa, College of Medicine. In 2004 he was named the Irwin H. Page Lecturer by the International Society for Serotonin Research and in 2006 he received the first Provost’s Outstanding Graduate Mentor award from Purdue University. He has published more than 300 scientific articles, most of which deal with the relationship between molecular structure and biological action.
Dr Nikola Ognyenovits
M.D., FRACGP, FACRRM, FACHAM (RACP)
Addiction Medicine Specialist Physician
Dr Nikola Ognyenovits is a Hungarian born Australian Addiction Medicine Specialist Physician living in Brisbane, Australia. He works in public alcohol and drug services and in private practice. After graduating as M.D. in 1987, he trained and worked in psychiatry, rural general practice, emergency medicine and aero-medical retrievals.
He was introduced to non-ordinary states of consciousness through Holotropic Breathwork and had the privilege of learning from Stanislav Grof and Tav Sparks. Dr Nikola has co-facilitated numerous breathwork sessions, trained with the Foundation of Shamanic Studies and participated in shamanic healing traditions globally.
After training in Ketamine Assisted Psychotherapy with The Ketamine Training Center, he has incorporated ketamine treatment into his private practice. He sees great potential in the application of ibogaine for addictions and has supported clients pre and post treatment. Dr Nikola is an advocate of the ethical and controlled use of psychedelic assisted psychotherapies in the treatment of addictions and associated mental health conditions.
Dr Thomas Pogge (USA)
Having received his PhD in philosophy from Harvard, Thomas Pogge is Leitner Professor of Philosophy and International Affairs and founding Director of the Global Justice Program at Yale. Pogge is a member of the Norwegian Academy of Science as well as co-founder of Academics Stand Against Poverty (ASAP), an international network aiming to enhance the impact of scholars, teachers and students on global poverty, and of Incentives for Global Health, a team effort toward developing a complement to the pharmaceutical patent regime that would improve access to advanced medicines for the poor worldwide.
His publications include Designing in Ethics, co-edited, Cambridge 2017; Global Tax Fairness, co-edited, Oxford 2016; Politics as Usual, Polity 2010; World Poverty and Human Rights, 2nd edition, Polity 2008; Global Justice and Global Ethics, co-edited, Paragon House 2008; John Rawls: His Life and Theory of Justice, Oxford 2007; and Freedom from Poverty as a Human Right, edited, Oxford & UNESCO 2007.
BSC (HONS), DIPM, GAICD, FIML, MIOD
Medicine Business Specialist
Nigel Pollard has a health industry background with 14 years in “big pharma” and 18 years in natural medicines. In the 90’s he worked in the HQ of a German pharmaceutical company and gave marketing guidance to the development of Humira®, now the no.1 selling medicine globally (US$20bn annually).
In 2001 Pollard established Flordis Natural Medicines to market natural health products with specific clinical evidence. Now called Soho Flordis International it is the only global Australian natural health company, with sales in 55+ countries and an unrivalled record of investing in 12 clinical trials.
Having stepped aside as global CEO in 2019, Pollard is a passionate advocate of informed choice based on the best scientific evidence. He Chairs a New York NFP, the Natural Health Science Foundation, and has a strong conviction that the best evidence options should be available to help address the mental health crisis.
Dr Prash Puspanathan
Masters in Psychological Medicine
Dr. Prash Puspanathan (also known as Dr. Prash P) has been a medical doctor at the Alfred Hospital where he most recently held the position of Neuropsychiatry Fellow.
Prash entered the field of Psychiatry so as to further his interest in the therapeutic potential of psychedelics. He has been an advocate on the importance of these medicine-assisted psychotherapies to the medical community, both in Australia and at conferences globally. He started and ran Psychonauts Onymous, Australia’s first monthly gathering of multidisciplinary professionals discussing current research into the psychedelic space. Outside of medicine, Prash is also the CEO of Caleb & Brown, Australia’s first dedicated Cryptocurrency brokerage. He was voted Young Executive of the Year by the Australia-wide Indian Executive Council in 2018.
A/Prof Sathya Rao
MBBS, MD (PSYCH MED), DPM, DNB (PSYCHIATRY), FRANZCP
Executive Clinical Director, Spectrum, Personality Disorder Service & Adjunct Clinical Associate Professor, Monash University
A/Prof Sathya Rao is a psychiatrist and the Executive Clinical Director of Spectrum, specialist service for personality disorders in Victoria. He is the Vice President of the Australian BPD Foundation. He is an adjunct clinical associate professor at Monash University. Dr Rao is involved in clinical research and has published research papers, contributed chapters and has co-authored books on Borderline Personality Disorder.
He was a member of the NHMRC Clinical Practice Guidelines development committee, 2012.
He has taught clinicians across Australia and was the head of psychiatry training program of Victoria for the RANZCP previously. He is involved in treating complex personality disorder patients and provides second opinions and secondary consultations for complex clinical conditions associated with personality disorders. He was the recipient of the 2020 Meritorious Award of the Victorian Branch of RANZCP.
Dr Jamie Rickcord
MBBS BSc (Hons) FRACGP
Founder Ananda Clinics
Dr Jamie has practised medicine since graduating from Imperial College, London in 2006 and for the last 8 years has worked as a GP in the Northern Rivers of NSW. He is the founder of Ananda Clinics in Byron Bay – one of Australia’s first to be dedicated to plant medicine. Jamie is an experienced prescriber of medicinal cannabis and is studying a Masters in Trauma Informed Psychotherapy. He is totally committed to the birth of a new paradigm in mainstream society where plant medicines are accepted as the remarkable gifts from nature that they are.
His interests are in healing trauma and the expansion of human potential. In his spare time Jamie surfs, plays his guitars and spends the rest of his time with his 3 year old son.
Dr Reid Robison (USA)
Psychedelic Psychiatrist & Researcher
Reid Robison, MD MBA, is a psychedelic psychiatrist & researcher who has led over 100 clinical trials in neuropsychiatry. Reid is co-founder at Cedar Psychiatry, and serves as Medical Director of Center for Change, a top Eating Disorder program. He is currently the coordinating investigator for the MAPS MDMA-assisted Psychotherapy study of Eating Disorders. As an early adopter and researcher of Ketamine in psychiatry, Reid obtained his first grant to study ketamine in 2011.
He also led the Utah site for the pivotal ketamine study for TRMDD by Janssen, leading up to the company’s recent FDA-approval of Spravato. To date, Reid has guided thousands of ketamine therapy journeys and hundreds of Spravato dosing sessions. As a social entrepreneur, Reid has built a number of purpose-driven companies including Tute Genomics, a venture-backed personalized medicine startup that was acquired in 2016. Reid is adjunct faculty at the University of Utah, founder of the Polizzi Free Clinic, and provides medical support and psychedelic therapy at plant medicine retreats abroad.
Dr Arne Rubinstein
Founder & CEO, The Rites of Passage Institute
Dr. Arne Rubinstein is an internationally recognised expert on Rites of Passage. His trainings and programs have been attended by over 200,000 people in more than 20 countries around the world and are now a part of over 50 schools around Australia.
Dr Arne is a medical doctor and specialised first in Family Medicine and then spent 15 years in Emergency Medicine until he moved full time creating Rites of Passage globally.
He is the author of the best-seller The Making of Men and has won multiple awards for his work including being nominated in 2008 for Australian of the Year for his groundbreaking work.
He has worked in Europe, The USA, Bhutan, Israel, Indonesia and supported the re-introduction of Rites of Passage for the Butchulla Aboriginal mob in Queensland. He is passionate about Rites of Passage becoming mainstream once again. Dr Arne is the proud father of two wonderful young men and a mentor to many others.
Dr James Rucker (UK)
BSC, MBBS(MD), MRCPSYCH, PHD
Consultant Psychiatrist & Senior Clinical Lecturer
James Rucker is a Consultant Psychiatrist and a Senior Clinical Lecturer in mood disorders and psychopharmacology at the Centre for Affective Disorders at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London (UK). James completed his medical degree at University College London (UK) in 2003 before training in psychiatry at the Maudsley, Bethlem and Springfield Hospitals in South London. He completed his PhD in the molecular biology of mood disorders at King’s College London in 2012.
He currently holds a 5 year Clinician Scientist Fellowship awarded by the National Institute for Health Research to investigate psilocybin as a treatment for major depressive disorder resistant to standard treatments. He leads the Psychedelic Trials Group, which is currently delivering three gold standard clinical trials using psilocybin in healthy volunteers and patients with resistant depression.
Dr Stuart Saker
General Adult Psychiatrist with an interest in Veterans’ Mental Health
Stuart Saker is a general adult psychiatrist working in the Lake Macquarie area near Newcastle, New South Wales. He did medicine at Sydney University and did Psychiatry training in Australia and the United Kingdom. He has been an Army Medical Officer and deployed 5 times. He has many veteran and first responders patients. He did MAPS training in MDMA assisted psychotherapy in Israel in 2008.
Prof Avni Sali AM
MBBS, Ph.D, FRACS, FACS, FACNEM
Founding Director of NIIM, and Member of the Scientific Board of The European Congress for Integrative Medicine.
He is former Head of Graduate School of Integrative Medicine, Swinburne University and the University of Melbourne Dept of Surgery, Heidelberg Hospital. Often referred to as the ‘Founding Father’ of Integrative Medicine, Prof Sali has pioneered leading research and education in the field of Integrative Medicine, as well as being a specialist in the clinical treatment of cancer and chronic disease. His integrative medicine books include: Co-authored, 2011 – ‘A guide to Evidence-Based Integrative and Complementary Medicine’ – Elsevier Australia, and 2017 ‘A Clinician’s Guide to Integrative Oncology’, Springer USA. In 2016 a book about his life was published entitled ‘Visionary Man, Visionary Medicine’. In 2016 he received an Order of Australia for “significant service to integrative medicine as an educator, clinician and researcher, and to professional education.”
Dr Patrycja Slawuta (USA)
Patrycja Slawuta is a New York City based behavioral scientist. She completed her Masters Degree at the University of Warsaw where here research centered around moral emotions of guilt and shame. Her academic work has been presented at various scientific conferences and published in articles and books on social psychology. After a successful academic career, Patrycja founded SelfHackathon, a boutique consultancy that uses cutting edge scientific research for business innovation. With a network of 50+ scientists and domain experts, SelfHackathon helps high performing individuals, teams and companies hack, rewire and upgrade themselves. Her latest initiative is called PsychTech, the seamless fusion of psychology and technology to enhance and accelerate performance and results. As an expert on the complexity, nonlinearity and the messiness of the human nature, Patrycja lectures globally and works with some of the most exciting and disruptive businesses in the world.
Prof Margaret Somerville
AM, FRSC, AuA(pharm), LLB(Hons), DCL
Margaret Somerville is Professor of Bioethics at the University of Notre Dame Australia, and, at McGill University, Montreal, Emerita Samuel Gale Professor of Law, Emerita Professor in the Faculty of Medicine and Emerita Founding Director of the Centre for Medicine, Ethics and Law.
Professor Somerville graduated in Pharmacy (University of Adelaide, 1963), Law (First class honours and University Medal, University of Sydney, 1973), and Doctor of Civil Law degree (McGill University, Montreal, 1978).
She has received eight honorary doctorates, was the first recipient of the UNESCO Avicenna Prize for Ethics in Science awarded by an international jury, has an extensive national and international publishing and speaking record and is a frequent commentator in all forms of media. Her 2006 CBC Massey Lectures were published as The Ethical Imagination: Journeys of the Human Spirit and her most recent book is Bird on an Ethics Wire: Battles about Values in the Culture War s (MQUP 2015).
Islamic scholar, educator, best-selling author and global speaker
Imam Mohammad Tawhidi is an Islamic scholar, educator, best-selling author, speaker, and one of the leading voices in the global movement of social Islamic reform. He has dedicated his life to ideologically tackling the spread of Islamic extremism and has delivered speeches at conferences, parliaments, mosques, Islamic centers, churches, synagogues, temples and universities across the Middle East, Europe, America, Asia, and Australia. He is licensed by Islamic leaders of the highest order to lead and represent the Muslim community. Tawhidi enjoys healthy international diplomatic relationships with numerous governments and provides regular advice on counter-terrorism. Imam Tawhidi was publicly ordained as an Islamic authority in the Holy City of Qum, Iran, by the Senior Grand Ayatollah Shirazi in 2010. He was recognized by the Senate of Canada on Wednesday June 13th of 2018, and is fluent in Arabic, English and Farsi.
Prof John Tiller
MD, MBCHB, BSC, DPM, FRACP, FRANZCP, GAICD
Professor Emeritus of Psychiatry, University of Melbourne
Dr Tiller qualified in medicine and science in New Zealand, holds a Doctorate of Medicine with his thesis on anxiety disorders from The University of Melbourne, is a Fellow of the Royal Australasian College of Physicians, a Fellow and Past President of the Royal Australian and New Zealand College of Psychiatrists, and is trained in child and adolescent psychiatry. He is a Graduate of the Australian Institute of Company Directors.
His primary research interests have been in the assessment and treatment of depressive and bipolar disorders, anxiety disorders including PTSD and psychoses. He is a recognized expert in ECT and psychopharmacology and has more than 300 scientific publications. He has an interest in governance, especially of not for profits – helping them being more effective in post graduate education and clinical services.
Dr Jeremy Weate (Canada)
CEO of Universal Ibogaine
Jeremy Weate has a PhD in philosophy from the University of Warwick. He has over 17 years strategic advisory experience, focused on minister-level guidance on the mining sector across over 50 projects in over 30 countries in Europe, Africa, Central Asia and the South Pacific. Jeremy also has a decade-long interest in the medicalization of ibogaine. In 2018, he helped set up Tabula Rasa Retreat in Portugal, now of the leading ibogaine treatment facilities globally. He has organised ibogaine conferences in Vienna, Porto and London.
He is CEO of the Vancouver-based Universal Ibogaine, which will IPO on the Toronto Stock Exchange later this year. Universal Ibogaine will take ibogaine through clinical trials in Canada, with a view to multi-country phase 3 trials in Canada, Australia, New Zealand and Israel. The company will launch holistically minded psychedelic-assisted therapy clinics in North America and subsequently globally this decade under the ClearSky Recovery brand.
Dr John Webber
MBBS, DPM, FRANZCP
Raised and educated in Melbourne, Australia, Dr John Webber, MBBS, DPM, FRANZCP completed his medical degree at Melbourne University and his intern years at the Royal Melbourne Hospital. Initially drawn to a surgical path, he was eventually drawn by his heart and life circumstances to a career in psychiatry. His first years of psychiatric training were at the Royal Melbourne Hospital psychiatry department, and his training later included a year at the Melbourne Neuropsychiatry Centre.
Dr Webber completed his specialist qualification through the Royal Australia and New Zealand College of Psychiatrists and has since worked in a successful private practice for over 30 years. His areas of interest include bipolar disorder, depressive disorders, hypnosis,and anxiety disorders, as well as mentoring young psychiatrists.
Dr Alex Wodak AM
Alex Wodak, a physician, is a Director of Australia 21 and is the President of the Australian Drug Law Reform Foundation. He was Director of the Alcohol and Drug Service, St Vincent’s Hospital, Sydney, from 1982 until he retired in 2012. Dr Wodak was the Foundation President of the International Harm Reduction Association (1996-2004) and helped to establish the National Drug and Alcohol Research Centre (1987), the NSW Users AIDS Association (1989), and the Australian Society of HIV Medicine (1989).
Rabbi Dr Laibl Wolf
Rabbi Dr Laibl Wolf is Dean and Founder of the Spiritgrow Wellness Centre, Melbourne, Australia. A graduate of Law and Psychology, he is a best-selling author and international acclaimed lecturer drawing on positive psychology side by side with ancient spiritual wisdoms.
An unusual blend of Hassidic Rabbi, therapist and teacher, he has presented at forums such as the Fortune 500 Convention, the International Psychology Conference, and the Gawler International Wellness Conventions. He was senior lecturer in Jewish spirituality at University of Melbourne and was personally consulted by the Dalai Lama. He lists Lord Rabbi Dr. Sir Jonathan Sacks as a good friend and colleague. His mentor was the revered Rabbi Menachem M. Schneerson (the Lubavitcher Rebbe obm).
Author of the best-selling, Practical Kabbalah (Random House), he has lectured in over 500 cities across the globe over 30 years on meditation, mindfulness and personal growth. The son of Polish holocaust survivors, he received his rabbinic ordination from the Chief Rabbi of Israel.
Dr Rachel Yehuda (USA)
Professor of Psychiatry and Neuroscience at the Icahn School of Medicine at Mount Sinai
Rachel Yehuda, Ph.D. is the Director of the Center for the Study of Psychedelic Psychotherapy and Trauma, Vice Chair for Veterans Affairs for the Psychiatry Department and a Professor of Psychiatry and Neuroscience at the Icahn School of Medicine at Mount Sinai as well as the Director of Mental Health at the Bronx Veterans Affairs Medical Center and the Director of the Traumatic Stress Studies Division.
Throughout her career her research has focused on the study of the enduring effects of trauma exposure, particularly PTSD, as well as associations between biological and psychological measures. She has investigated novel treatment approaches for PTSD and the biological factors that may contribute to differing treatment outcomes for the purpose of developing personalized medicine strategies for treatment matching in PTSD.
This work has resulted in an approved US patent for a PTSD blood test. Recently, Dr Yehuda’s laboratory has used advances in stem cell technology to examine PTSD gene expression networks in induced neurons. The Center for Psychedelic Psychotherapy and Trauma integrates sophisticated brain imaging and molecular neuroscience in PTSD with clinical trials using MDMA assisted psychotherapy and other related medicines. She has authored more than 450 published papers, chapters, and books in the field of trauma and resilience, focusing on topics such as PTSD prevention and treatment, molecular biomarkers of stress vulnerability and resilience, and intergenerational effects of trauma and PTSD.